“…Since then, results from completed and on---going screening studies and programmes have been published, among other things revealing that the prevalence is considerably lower, the attendance rate is higher, the rate of opportunistic detection is greater, the costs associated with surgery have changed, e.g. due to shorter ICU---stay and increased use of EVAR, operative mortality rate has decreased and general survival (not related to AAA) in the population has increased (Svensjo et al 2011, Darwood et al 2012. Although previous studies have indicated that screening for AAA appears cost---effective and that the results are robust to changes in input parameters, updated analyses in a different context are warranted due to changed circumstances and the availability of data from screening programmes in healthcare practice.…”